These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4907517

  • 1. Treatment of persistent phenothiazine-induced oral dyskinesia.
    Roxburgh PA.
    Br J Psychiatry; 1970 Mar; 116(532):277-80. PubMed ID: 4907517
    [No Abstract] [Full Text] [Related]

  • 2. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK, Muzekari LH, Shanken PM.
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract] [Full Text] [Related]

  • 3. Sustained relief of hemiballismus.
    Rowlands IP.
    Br Med J; 1972 Apr 29; 2(5808):296. PubMed ID: 4259962
    [No Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
    Crane GE.
    Am J Psychiatry; 1968 Feb 29; 124(8):Suppl:40-8. PubMed ID: 4865731
    [No Abstract] [Full Text] [Related]

  • 5. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM, Amin M, Kunz-Bartholini E, Watts TP, Laska E.
    Dis Nerv Syst; 1968 Jul 29; 29(7):478-84. PubMed ID: 4386374
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul 29; 27(1):100-3. PubMed ID: 4555826
    [No Abstract] [Full Text] [Related]

  • 7. Persistent phenothiazine dyskinesia treated with tetrabenazine.
    Godwin-Austen RB, Clark T.
    Br Med J; 1971 Oct 02; 4(5778):25-6. PubMed ID: 4938245
    [Abstract] [Full Text] [Related]

  • 8. Persistent oral dyskinesia in female mental hospital patients.
    Pryce IG, Edwards H.
    Br J Psychiatry; 1966 Oct 02; 112(491):983-7. PubMed ID: 5970925
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE, Ruiz P, Kernohan WJ, Wilson W, Royalty N.
    Act Nerv Super (Praha); 1969 Oct 02; 11(1):30-5. PubMed ID: 5770140
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phenothiazine-induced dyskinesia in nursing-home patients.
    Greenblatt DL, Dominick JR, Stotsky BA, DiMascio A.
    J Am Geriatr Soc; 1968 Jan 02; 16(1):27-34. PubMed ID: 4863733
    [No Abstract] [Full Text] [Related]

  • 14. Thiopropazate hydrochloride in persistent dyskinesia.
    Singer K, Cheng MN.
    Br Med J; 1971 Dec 04; 4(5787):626. PubMed ID: 5167074
    [No Abstract] [Full Text] [Related]

  • 15. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
    McAndrew JB, Case Q, Treffert DA.
    J Autism Child Schizophr; 1972 Dec 04; 2(1):75-91. PubMed ID: 5067403
    [No Abstract] [Full Text] [Related]

  • 16. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V, Valenová Z, Paceltová L.
    Cesk Psychiatr; 1969 Aug 04; 65(4):241-4. PubMed ID: 5807247
    [No Abstract] [Full Text] [Related]

  • 17. Persistent dyskinesia.
    Crane GE.
    Br J Psychiatry; 1973 Apr 04; 122(569):395-405. PubMed ID: 4577946
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of lobotomized schizophrenic patients with butaperazine.
    Holden JM, Itil TM, Keskiner A.
    Curr Ther Res Clin Exp; 1969 Jul 04; 11(7):418-28. PubMed ID: 4390417
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.